Goldfarb, David S.
Chen, Jing Voon
Zincavage, Rebekah
Padilla, Brad
Sussman, Matthew
Salem, Sandra
Modersitzki, Frank
Article History
Received: 15 October 2024
Accepted: 16 April 2025
First Online: 14 May 2025
Declarations
:
: Before enrollment of patients into this study, the protocol, ICF, any promotional material/advertisements, and any other written information to be provided to participants have been reviewed and approved by the IRB (tracking number 20234228).
: Not applicable.
: DSG is a consultant for Novo Nordisk, Alnylam, Arbor Biotechnologies, and Lilac Pharmaceuticals; Owner of Moonstone Nutrition Inc. FM is a consultant for Travere and Antares Pharma. JVC is an employee of Genesis Research Group, which received payment from Novo Nordisk Inc to oversee this research. RZ, BP, and MS are employees of Stratevi, LLC, which received payment from Novo Nordisk Inc to design, implement, and interpret findings from this research. SS is an employee of Novo Nordisk Inc.